Archive | Second Opinion

This website uses cookies

Read our Privacy policy and Terms of use for more information.

Roundup

+3

Abridge’s big announcement

Jun 13, 2026

•

9 min read

Abridge’s big announcement

And a conversation with CEO Shiv Rao

Ruth Reader, +2

Healthtech

+2

Healthcare companies are drowning in a “sea of sameness,” says veteran comms pro

Jun 11, 2026

•

5 min read

Healthcare companies are drowning in a “sea of sameness,” says veteran comms pro

Why every healthcare company sounds the same and what to do about it

Tori Barnes

Women's Health

+5

If the ACCESS Model works, should it be expanded to Medicaid?

Jun 10, 2026

•

6 min read

If the ACCESS Model works, should it be expanded to Medicaid?

Experts inside and outside the government tell us what they think..

Christina Farr, +1

Healthtech

+2

What's behind the rapid rise in virtual menopause care

Jun 9, 2026

•

7 min read

What's behind the rapid rise in virtual menopause care

It's not just about demand.

Sarah Thomas, +2

Roundup

+3

The food industry considers GLP-1s

Jun 7, 2026

•

10 min read

The food industry considers GLP-1s

Lawmakers have to approve a new law, which is mixed on how much taxpayers should foot the bill for healthy foods, while food manufacturers are revising their strategies for the weight-loss drug era.

Christina Farr, +2

specialty-trained AI agents in medicine

+3

Exclusive: Amazon's Health AI Bot Exposes a Flaw in Patient Data Access

Jun 5, 2026

•

5 min read

Exclusive: Amazon's Health AI Bot Exposes a Flaw in Patient Data Access

Experts are weighing the ethics and security vulnerabilities of allowing bots to access patient data as doctors do.

Ruth Reader

Health IT

+4

A guide to getting healthcare partnerships to work

Jun 3, 2026

•

9 min read

A guide to getting healthcare partnerships to work

Generate revenue, not just headlines

Christina Farr, +1

Patient Acquisition

+3

Large Language Models don't reason better than physicians - yet

Jun 1, 2026

•

5 min read

Large Language Models don't reason better than physicians - yet

The second edition of SIGNAL, our new health AI review column

Dr. Shantanu Nundy

Roundup

+5

AI drug discovery’s expensive reality

May 30, 2026

•

10 min read

AI drug discovery’s expensive reality

Rising compute costs have biotech firms rethinking how they use large language models.

Christina Farr, +2